Skip to main content

Apogee Therapeutics, Inc.

APGEDelisted Sep 3, 2026
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001974640

Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2025

Institutional positions in Apogee Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
174
−8 vs. Q2 2025
Shares held
59.6M
+1.75M (+3.0%) vs. Q2 2025
Total value
$2.37B
−$144.0M (−5.7%) vs. Q2 2025
New holders
25
63 more added
Sold out
33
57 more reduced

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting APGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 174 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 73 institutionsQ4 2023: 85 institutionsQ1 2024: 139 institutionsQ2 2024: 139 institutionsQ3 2024: 139 institutionsQ4 2024: 158 institutionsQ1 2025: 169 institutionsQ2 2025: 183 institutionsQ3 2025: 174 institutionsQ4 2025: 207 institutionsQ1 2026: 224 institutionsQ2 2026: 288 institutions
Value heldQ3 2025: $2.37B
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $848.7MQ4 2023: $1.16BQ1 2024: $3.52BQ2 2024: $2.13BQ3 2024: $3.29BQ4 2024: $2.62BQ1 2025: $2.30BQ2 2025: $2.51BQ3 2025: $2.37BQ4 2025: $5.27BQ1 2026: $6.64BQ2 2026: $8.93B
Institutions holding APGE and their total value by quarter
QuarterHoldersValue
Q2 2026288$8.93B
Q1 2026224$6.64B
Q4 2025207$5.27B
Q3 2025174$2.37B
Q2 2025183$2.51B
Q1 2025169$2.30B
Q4 2024158$2.62B
Q3 2024139$3.29B
Q2 2024139$2.13B
Q1 2024139$3.52B
Q4 202385$1.16B
Q3 202373$848.7M
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Apogee Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding APGE in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−3,813−100.0%Sold out
Quarry LP0$00.00%−1,930−100.0%Sold out
Group One Trading, L.P.0$00.00%−185−100.0%Sold out
Skopos Labs, Inc.0$00.00%−92−100.0%Sold out
Leonteq Securities AG0$00.00%−73−100.0%Sold out
UMA Financial Services, Inc.0$00.00%−18−100.0%Sold out
Raymond James Financial Inc0$00.00%−8−100.0%Sold out
E Fund Management Co., Ltd.––––Not filed